ReviewEvidence-based complementary and alternative medicine : eCAM2020
NLRP3 Inflammasome: A Potential Alternative Therapy Target for Atherosclerosis.
Yang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it